Looking for cheap big pharma stocks? These five deserve some attention.
It's hard to believe, but over the past year, the pharmaceutical industry has fared worse in the stock market than the energy sector. Some sword-rattling from political candidates sent the SPDR S&P Pharmaceutical ETF (NYSEMKT: XPH) crashing to a level it hasn't seen since late 2013.
Despite the recent drop, the ETF tracking bigger pharmas is still miles ahead of the broad market. And although the industry as a whole has fallen out of favor recently, I believe once the dust settles after November this group will continue its march upwards.
In the meantime, a handful of big pharmas are trading at ridiculously low prices based on their forward earnings estimates. Shares of Allergan (NYSE:AGN), Merck & Co. (NYSE:MRK), Novartis (NYSE:NVS), Pfizer (NYSE:PFE), and Roche (NASDAQOTH:RHHBY) are trading at clearance rack prices.
Let's take a closer look at some of the individual bargains…
Source: TheMotley Fool